Everything you need to know about the the Season 2 finale of ‘The Pitt’ as Dr. Robby and his team of ER docs and nurses wraps up yet another stressful shift.
AI is making it easier to design chips and optimize software for different silicon. Some startups envision a revolution in chipmaking.
Quarterly RNA drug plozasiran turns off a liver gene, sharply lowering life‑threatening pancreatitis attacks in a rare genetic disorder.
Berkeley’s Hany Farid says humans can barely spot AI-generated content. Every court, claim file and contract that depends on human judgment needs a backup plan.
TV has a best new show, not one that’s back for another season, but a brand new offering. It deserves its amazing Rotten Tomatoes score.
Allbirds had a hit a decade ago with its Wool Runner shoes, but after a $4 billion IPO in 2021, the business never turned a profit, and sales dropped nearly 50 percent between 2022 and 2025. The company recently announced it would sell off its name and assets for $39 million to American Exchange after […]
In this week’s edition of InnovationRx, we look at the top self-made healthcare entrepreneurs, the latest 30 Under 30 Science & Healthcare list, and more.
Generative AI has opened medical record forgery to a much wider pool of bad actors. Defense requires layers—AI, human in the loop, and digital forensics.
Once a $4 billion apparel juggernaut, Allbirds will rebrand as NewBird AI, a “GPU-as-a-Service” company. Hey, if you can’t beat ’em, join ’em.
It has been a long time since a new show was popular enough to make Netflix’s top 10 list of its all-time most viewed series. But one has.